细菌学检测市场－全球产业规模、份额、趋势、机会及预测（依细菌种类、技术、应用、组件、地区及竞争格局划分，2021-2031年）

全球细菌学检测市场预计将从 2025 年的 277.4 亿美元成长到 2031 年的 433.2 亿美元，复合年增长率达到 7.71%。

本行业运用分析技术检测、识别和测量各种基材（包括食品、自来水和临床检体）中的细菌污染物，以确保安全性和合规性。市场成长的主要驱动力是政府对品质标准的严格执行以及全球感染疾病日益普遍，这需要严格的监测和控制策略。此外，对预防性医疗保健的日益重视以及工业界对快速病原体检测方法的需求不断增长，也为该行业的发展提供了支持。

儘管市场成长前景强劲，但由于先进诊断技术的高昂营运成本和复杂的法规环境，市场仍面临许多挑战。中小企业往往难以承担认证和设备维护带来的财务负担，这可能会延缓创新检测方案的推出。根据欧洲医疗技术协会（MedTech Europe）预测，到2024年，体外诊断医疗设备法规（IDMDR）下的品管系统认证平均成本将达到约108,307欧元，这凸显了製造商在将新检测产品推向市场时面临的巨大财务障碍。

市场驱动因素

食源性疾病和食品污染事件的日益增加是推动细菌学检测普及的主要因素。製造商面临建立严格筛检程序的压力，以防止因污染事件导致代价高昂的产品召回，而联邦政府为加强监管提供的资金进一步凸显了这一需求。例如，2024年3月，美国食品药物管理局（FDA）申请了总额为72亿美元的2025财年计画资金，用于加强食品和医疗产品安全。 2024年8月，美国疾病管制与预防中心（CDC）报告了一起与熟食肉品相关的大规模细胞增生李斯特菌集体爆发，这凸显了该项资金申请的紧迫性。该事件导致57人住院，并暴露了其对公共卫生的影响，凸显了诊断解决方案的必要性。

第二个关键驱动因素是日益增长的水质监测需求，这主要源自于严格的环境法规和污水安全要求。地方政府正在加强检测能力，以识别细菌指标并确保符合监管规定，而政府则透过为基础设施升级提供财政支持来协助这些工作。 2024年3月，英国环境、食品和农村事务部宣布了一项优先投资计划，旨在减少废水溢流，并拨款1.8亿英镑用于加速改善污水管理。这笔资金将直接用于增加检测套组和实验室服务的采购，而这些对于环境监测至关重要。

市场挑战

高昂的营运成本和与先进诊断技术相关的复杂监管环境，对全球细菌检测市场的发展构成了重大障碍。製造商面临越来越大的财务压力，必须满足严格的认证标准，这迫使他们将大量资源从研发转移到合规和政府文件编制上。这种资金的重新分配抑制了创新，并延缓了下一代细菌检测解决方案的上市。因此，中小企业往往难以业务永续营运，导致市场整合加剧，可供选择的诊断工具种类减少。

这些监管负担迫使企业重新评估其地理策略和产品上市时间，直接阻碍了市场扩张。当获得监管核准所需的投资过高时，製造商往往会推迟进入监管严格的市场，或撤回那些不再具有商业性可行性的现有产品。根据2024年欧洲医疗技术展（MedTech Europe）的数据，这些限制导致选择欧盟作为产品首发优先区域的大型体外诊断试剂製造商比例下降了40%，中小企业比例下降了12%。这一趋势表明，合规挑战正在积极减缓市场成长，并限制强制性安全测试机制在全球的普及。

市场趋势

快速分子诊断技术的整合正在从根本上改变市场格局，它以更快速、更具针对性的检测方法取代了耗时的培养方法。检查室越来越多地使用多重检测板，这种检测板可以同时检测单一检体中的多种细菌和病毒，从而显着缩短检测结果的周转时间，并有助于更快地做出临床决策。这种转变在对照护现场分子诊断系统的强劲需求中尤为明显，这些系统使先进的检测更贴近患者，并改善了分散式医疗环境中的管理。根据生物梅里埃公司于2024年4月发布的“2024年第一季业务回顾”，该公司分子生物学部门的销售额同比增长18%，主要得益于非呼吸道检测板销售额增长19%以及该季度成功部署了400套新的SpotFire系统。

同时，随着微生物检查室寻求透过机器人和人工智慧优化工作流程效率并解决技术纯熟劳工短缺问题，向高通量检测自动化转型正在加速。这一趋势包括部署自动化检体处理设备、智慧培养箱和数位成像系统，这些设备能够标准化检体处理流程并简化菌落分析。透过自动化诸如接种、分类和挑取等重复性任务，实验室可以更有效率、更可追溯地处理大量检体，从而有效地将传统的手动工作流程转变为全数数位化操作。根据 Copan 集团 2024 年 10 月宣布在赫尔辛基 HUS 诊断中心安装其首个斯堪地那维亚Colibri™ 系统的消息，该公司已在全球安装了 90 多套自动化菌落挑取系统，其中 40 套专门安装在欧洲，旨在提升细菌学自动化水平。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球细菌学检测市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 细菌类型（大肠桿菌群、沙门氏菌、曲状桿菌、李斯特菌、退伍军人菌、其他）
  • 依技术（传统技术与快速技术）划分
  • 依应用领域（食品饮料、水、药品等）
  • 依组成部分（设备、检测套组、试剂和耗材）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美微生物检测市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲微生物检测市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区微生物检测市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲微生物检测市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲微生物检测市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球细菌学检测市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• SGS SA
• Bureau Veritas SA
• Intertek Group plc
• Eurofins Scientific SE
• TUV SUD AG
• ALS Limited
• 3M Company
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Agilent Technologies, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Bacteriological Testing Market is projected to expand from USD 27.74 Billion in 2025 to USD 43.32 Billion by 2031, achieving a compound annual growth rate of 7.71%. This sector involves analytical techniques designed to detect, identify, and measure bacterial contaminants in diverse substrates, such as food products, water supplies, and clinical samples, to ensure safety and regulatory compliance. The market's growth is primarily fueled by the strict enforcement of government quality standards and the rising global prevalence of infectious diseases, which demand rigorous surveillance and control strategies. Additionally, the industry is supported by a growing focus on preventive healthcare and increasing industrial needs for rapid pathogen detection methods.

Despite these favorable growth prospects, the market faces significant hurdles due to the high operational costs of advanced diagnostic technologies and a complex regulatory environment. Small and medium-sized enterprises frequently struggle to manage the financial strain of certification and equipment maintenance, which can delay the adoption of innovative testing solutions. According to MedTech Europe, the average cost for quality management system certification under the In Vitro Diagnostic Regulation reached approximately €108,307 in 2024, highlighting the substantial economic barriers manufacturers encounter when introducing new testing products to the market.

Market Driver

The escalating incidence of foodborne illnesses and contamination outbreaks is a major force accelerating the adoption of bacteriological testing. Manufacturers are driven to establish rigorous screening protocols to prevent contamination incidents that result in expensive product recalls, a necessity further emphasized by federal funding designed to improve oversight. For instance, the U.S. Food and Drug Administration requested a total program funding level of $7.2 billion in March 2024 for the 2025 fiscal year to enhance the safety of food and medical products. The real-world urgency of this demand is validated by events such as the significant Listeria outbreak linked to deli meats reported by the Centers for Disease Control and Prevention in August 2024, which caused 57 hospitalizations and demonstrated the public health consequences that drive the need for diagnostic solutions.

A second critical driver is the increasing demand for water quality monitoring, propelled by strict environmental regulations and wastewater safety requirements. Municipalities are intensifying their testing regimes to identify bacterial indicators and ensure compliance, while governments support these efforts with financial commitments to upgrade infrastructure. According to a March 2024 announcement by the UK Department for Environment, Food & Rural Affairs regarding fast-tracked investments to reduce sewage spills, £180 million was allocated to accelerate wastewater management improvements. This capital directly leads to increased procurement of testing kits and laboratory services essential for environmental surveillance.

Market Challenge

The steep operational costs linked to advanced diagnostic technologies and the intricate regulatory landscape create a significant barrier to progress in the Global Bacteriological Testing Market. Manufacturers are under increasing financial pressure to meet rigorous certification standards, forcing them to divert essential resources from research and development toward compliance and administrative documentation. This reallocation of capital hampers innovation and delays the launch of next-generation bacteriological testing solutions. Consequently, smaller enterprises often find it difficult to sustain operations, resulting in market consolidation and a reduction in the variety of available diagnostic tools.

These regulatory burdens directly inhibit market expansion by compelling companies to rethink their geographic strategies and product launch timelines. When the investment required for regulatory approval becomes excessive, manufacturers often delay entry into strict markets or withdraw existing products that are no longer commercially viable. Data from MedTech Europe in 2024 indicates that the selection of the European Union as the priority region for first product launches dropped by 40% for large in vitro diagnostic manufacturers and 12% for small and medium-sized enterprises due to these constraints. This trend demonstrates how compliance challenges actively slow market growth and limit the global availability of essential safety testing mechanisms.

Market Trends

The integration of Rapid Molecular Diagnostic Technologies is fundamentally transforming the market by replacing time-consuming culture methods with faster, syndromic testing approaches. Laboratories are increasingly utilizing multiplex panels that can simultaneously detect multiple bacteria and viruses from a single sample, drastically reducing turnaround times and facilitating quicker clinical decision-making. This shift is particularly evident in the robust demand for point-of-care molecular systems that bring sophisticated testing closer to the patient, thereby improving management in decentralized settings. As reported in BioMerieux's 'First-Quarter 2024 Business Review' from April 2024, sales in the company's molecular biology division rose by 18% year-on-year, driven largely by a 19% increase in non-respiratory panels and the successful installation of 400 new SpotFire systems during the quarter.

Simultaneously, the shift toward High-Throughput Laboratory Automation is accelerating as microbiology labs seek to optimize workflow efficiency and address skilled labor shortages through robotics and artificial intelligence. This trend involves the adoption of automated specimen processors, smart incubators, and digital imaging systems that standardize sample handling and streamline colony analysis. By automating repetitive tasks such as plating, streaking, and picking, facilities can process higher volumes of samples with greater consistency and traceability, effectively converting traditional manual workflows into fully digitized operations. According to Copan Group's October 2024 announcement regarding the first Colibri(TM) installation in Scandinavia at Helsinki's HUS Diagnostic Center, the company has successfully deployed more than 90 automated colony picking systems globally, with 40 units specifically installed across Europe to enhance bacteriology automation.

Key Market Players

• SGS SA
• Bureau Veritas SA
• Intertek Group plc
• Eurofins Scientific SE
• TUV SUD AG
• ALS Limited
• 3M Company
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Agilent Technologies, Inc.

Report Scope

In this report, the Global Bacteriological Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bacteriological Testing Market, By Bacteria

• Coliform
• Salmonella
• Campylobacter
• Listeria
• Legionella and Others

Bacteriological Testing Market, By Technology

• Traditional Technology and Rapid Technology

Bacteriological Testing Market, By End Use

• Food & Beverage
• Water
• Pharmaceuticals and Others

Bacteriological Testing Market, By Component

• Instruments
• Test Kits and Reagents & Consumables

Bacteriological Testing Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bacteriological Testing Market.

Available Customizations:

Global Bacteriological Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bacteriological Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Bacteria (Coliform, Salmonella, Campylobacter, Listeria, Legionella and Others)
  • 5.2.2. By Technology (Traditional Technology and Rapid Technology)
  • 5.2.3. By End Use (Food & Beverage, Water, Pharmaceuticals and Others)
  • 5.2.4. By Component (Instruments, Test Kits and Reagents & Consumables)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Bacteriological Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Bacteria
  • 6.2.2. By Technology
  • 6.2.3. By End Use
  • 6.2.4. By Component
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bacteriological Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Bacteria
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By End Use
      • 6.3.1.2.4. By Component
  • 6.3.2. Canada Bacteriological Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Bacteria
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By End Use
      • 6.3.2.2.4. By Component
  • 6.3.3. Mexico Bacteriological Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Bacteria
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By End Use
      • 6.3.3.2.4. By Component

7. Europe Bacteriological Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Bacteria
  • 7.2.2. By Technology
  • 7.2.3. By End Use
  • 7.2.4. By Component
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Bacteriological Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Bacteria
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By End Use
      • 7.3.1.2.4. By Component
  • 7.3.2. France Bacteriological Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Bacteria
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By End Use
      • 7.3.2.2.4. By Component
  • 7.3.3. United Kingdom Bacteriological Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Bacteria
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By End Use
      • 7.3.3.2.4. By Component
  • 7.3.4. Italy Bacteriological Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Bacteria
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By End Use
      • 7.3.4.2.4. By Component
  • 7.3.5. Spain Bacteriological Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Bacteria
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By End Use
      • 7.3.5.2.4. By Component

8. Asia Pacific Bacteriological Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Bacteria
  • 8.2.2. By Technology
  • 8.2.3. By End Use
  • 8.2.4. By Component
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Bacteriological Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Bacteria
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By End Use
      • 8.3.1.2.4. By Component
  • 8.3.2. India Bacteriological Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Bacteria
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By End Use
      • 8.3.2.2.4. By Component
  • 8.3.3. Japan Bacteriological Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Bacteria
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By End Use
      • 8.3.3.2.4. By Component
  • 8.3.4. South Korea Bacteriological Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Bacteria
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By End Use
      • 8.3.4.2.4. By Component
  • 8.3.5. Australia Bacteriological Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Bacteria
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By End Use
      • 8.3.5.2.4. By Component

9. Middle East & Africa Bacteriological Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Bacteria
  • 9.2.2. By Technology
  • 9.2.3. By End Use
  • 9.2.4. By Component
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Bacteriological Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Bacteria
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By End Use
      • 9.3.1.2.4. By Component
  • 9.3.2. UAE Bacteriological Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Bacteria
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By End Use
      • 9.3.2.2.4. By Component
  • 9.3.3. South Africa Bacteriological Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Bacteria
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By End Use
      • 9.3.3.2.4. By Component

10. South America Bacteriological Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Bacteria
  • 10.2.2. By Technology
  • 10.2.3. By End Use
  • 10.2.4. By Component
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Bacteriological Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Bacteria
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By End Use
      • 10.3.1.2.4. By Component
  • 10.3.2. Colombia Bacteriological Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Bacteria
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By End Use
      • 10.3.2.2.4. By Component
  • 10.3.3. Argentina Bacteriological Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Bacteria
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By End Use
      • 10.3.3.2.4. By Component

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Bacteriological Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. SGS SA
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bureau Veritas SA
• 15.3. Intertek Group plc
• 15.4. Eurofins Scientific SE
• 15.5. TUV SUD AG
• 15.6. ALS Limited
• 15.7. 3M Company
• 15.8. Thermo Fisher Scientific Inc.
• 15.9. Merck KGaA
• 15.10. Agilent Technologies, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer